These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25779319)

  • 1. Measuring efflux and permeability in mycobacteria.
    Rodrigues L; Viveiros M; Aínsa JA
    Methods Mol Biol; 2015; 1285():227-39. PubMed ID: 25779319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Efflux and Permeability in Mycobacteria.
    Rodrigues L; Aínsa JA; Viveiros M
    Methods Mol Biol; 2021; 2314():231-245. PubMed ID: 34235655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
    Solnier J; Martin L; Bhakta S; Bucar F
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.
    Rodrigues L; Villellas C; Bailo R; Viveiros M; Aínsa JA
    Antimicrob Agents Chemother; 2013 Feb; 57(2):751-7. PubMed ID: 23165464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mycobacterial efflux transporters in drug resistance: an unresolved question.
    De Rossi E; Aínsa JA; Riccardi G
    FEMS Microbiol Rev; 2006 Jan; 30(1):36-52. PubMed ID: 16438679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
    Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
    BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
    Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
    Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial efflux pumps and chemotherapeutic implications.
    Viveiros M; Leandro C; Amaral L
    Int J Antimicrob Agents; 2003 Sep; 22(3):274-8. PubMed ID: 13678834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
    Lechner D; Gibbons S; Bucar F
    J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
    Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
    J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.
    Guglierame P; Pasca MR; De Rossi E; Buroni S; Arrigo P; Manina G; Riccardi G
    BMC Microbiol; 2006 Jul; 6():66. PubMed ID: 16857052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method.
    Martins M; Viveiros M; Couto I; Costa SS; Pacheco T; Fanning S; Pagès JM; Amaral L
    In Vivo; 2011; 25(2):171-8. PubMed ID: 21471531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus.
    Dymek A; Armada A; Handzlik J; Viveiros M; Spengler G; Molnar J; Kieć-Kononowicz K; Amaral L
    In Vivo; 2012; 26(2):223-9. PubMed ID: 22351662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.
    Viveiros M; Martins M; Rodrigues L; Machado D; Couto I; Ainsa J; Amaral L
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):983-98. PubMed ID: 23106274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Mycobacterium vanbaalenii as a model organism to study drug transporters of Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans: homology analysis of M. tuberculosis drug transporters among mycobacterial species.
    Gupta AK; Katoch VM; Chauhan DS; Lavania M
    Infect Genet Evol; 2012 Jun; 12(4):853-6. PubMed ID: 22127144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.
    Viveiros M; Martins A; Paixão L; Rodrigues L; Martins M; Couto I; Fähnrich E; Kern WV; Amaral L
    Int J Antimicrob Agents; 2008 May; 31(5):458-62. PubMed ID: 18343640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.
    Marchi E; Furi L; Arioli S; Morrissey I; Di Lorenzo V; Mora D; Giovannetti L; Oggioni MR; Viti C
    Microbiol Res; 2015 Jan; 170():184-94. PubMed ID: 25081379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.